National Lung Matrix Trial

The National Lung Matrix Trial is the largest precision medicine trial in non-small cell lung cancer globally, testing a wide-range of therapies tailored specifically to target key genetic changes in cancer cells.

Stratified Medicine Programme 2


Cancer Research UK’s Stratified Medicine Programme 2 provides national genomic pre-screening for patients with Non-Small Cell Lung cancer, and is required to determine patient molecular eligibility for the National Lung Matrix Trial.

  Find out more   

Also in 'National Lung Matrix Trial'